1. Simons FER, Ardusso LRF, Bilò MB, Gamal YME, Ledford DK, Ring J, et al. World Allergy Organization guidelines for the assessment and management of anaphylaxis. World Allergy Organ J. 2011;4:13‑37.

2. Bernd LAG, Sá AB, Watanabe AS, Castro APM, Solé D, Castro FM, et al. Guia prático para o manejo da anafilaxia-2012. Rev Bras Alerg Imunopatol. 2012,35:53-70.

3. Ribeiro MLKK, Barcellos AC, Silva HGF, Carletto LHM, Bet MC, Rossetto NC, et al. Arq Asma Alerg Immunol. 2017;2:217-25.

4. Altman AM, Camargo Jr CA, Simons FER, Lieberman P, Sampson HA, Schwartz LB, et al. Anaphylaxis in America: a national physician survey. J Allergy Clin Immunol. 2015;135:830-3.

5. Sole D, Ivancevich JC, Borges MS, Coelho MA, Rosario NA, Ardusso LRF, et al. Anaphylaxis in Latin America: a report of the online Latin American survey on anaphylaxis (OLASA). Clinics. 2011;66:943-7.

6. Manivannan V, Hess EP, Venkatesh RB, Nestler DM, Bellolio MF, Hagan JB, et al. A multifaceted intervention increases epinephrine use in adult emergency department anaphylaxis patients. J Allergy Clin Immunol Pract. 2014;2:294-9.

7. Desjardins M, Clarke A, Alizadehfar R, Grenier D, Eisman H, Carr S, et al. Canadian allergists' and nonallergists' perception of epinephrine use and vaccination of persons with egg allergy. J Allergy Clin Immunol Pract. 2013;1:289-94.

8. Mehl A, Wahn U, Niggemann. Anaphylactic reactions in children: a questionnaire-based survey in Germany. Allergy. 2005:60:1440-5.